List of Tables
Table 1. Global Biosimilars of Factor X agonists Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Biosimilars of Factor X agonists Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Biosimilars of Factor X agonists Market Competitive Situation by Manufacturers in 2025
Table 4. Global Biosimilars of Factor X agonists Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Biosimilars of Factor X agonists Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Biosimilars of Factor X agonists Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Biosimilars of Factor X agonists Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Biosimilars of Factor X agonists Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Biosimilars of Factor X agonists, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Biosimilars of Factor X agonists, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Biosimilars of Factor X agonists, Product Types and Applications
Table 12. Global Key Manufacturers of Biosimilars of Factor X agonists, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Biosimilars of Factor X agonists Companies by Tier (Tier 1, Tier 2, Tier 3), based on Biosimilars of Factor X agonists Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Biosimilars of Factor X agonists Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Biosimilars of Factor X agonists Sales by Region (K Units), 2021–2026
Table 18. Global Biosimilars of Factor X agonists Sales Market Share by Region (2021–2026)
Table 19. Global Biosimilars of Factor X agonists Sales by Region (K Units), 2027–2032
Table 20. Global Biosimilars of Factor X agonists Sales Market Share by Region (2027–2032)
Table 21. Global Biosimilars of Factor X agonists Revenue by Region (US$ Million), 2021–2026
Table 22. Global Biosimilars of Factor X agonists Revenue Market Share by Region (2021–2026)
Table 23. Global Biosimilars of Factor X agonists Revenue by Region (US$ Million), 2027–2032
Table 24. Global Biosimilars of Factor X agonists Revenue Market Share by Region (2027–2032)
Table 25. North America Biosimilars of Factor X agonists Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Biosimilars of Factor X agonists Sales by Country (K Units), 2021–2026
Table 27. North America Biosimilars of Factor X agonists Sales by Country (K Units), 2027–2032
Table 28. North America Biosimilars of Factor X agonists Revenue by Country (US$ Million), 2021–2026
Table 29. North America Biosimilars of Factor X agonists Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Biosimilars of Factor X agonists Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Biosimilars of Factor X agonists Sales by Country (K Units), 2021–2026
Table 32. Europe Biosimilars of Factor X agonists Sales by Country (K Units), 2027–2032
Table 33. Europe Biosimilars of Factor X agonists Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Biosimilars of Factor X agonists Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Biosimilars of Factor X agonists Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Biosimilars of Factor X agonists Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Biosimilars of Factor X agonists Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Biosimilars of Factor X agonists Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Biosimilars of Factor X agonists Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Biosimilars of Factor X agonists Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Biosimilars of Factor X agonists Sales by Country (K Units), 2021–2026
Table 42. Latin America Biosimilars of Factor X agonists Sales by Country (K Units), 2027–2032
Table 43. Latin America Biosimilars of Factor X agonists Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Biosimilars of Factor X agonists Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Biosimilars of Factor X agonists Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Biosimilars of Factor X agonists Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Biosimilars of Factor X agonists Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Biosimilars of Factor X agonists Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Biosimilars of Factor X agonists Revenue by Country (US$ Million), 2027–2032
Table 50. Global Biosimilars of Factor X agonists Sales (K Units) by Type (2021–2026)
Table 51. Global Biosimilars of Factor X agonists Sales (K Units) by Type (2027–2032)
Table 52. Global Biosimilars of Factor X agonists Sales Market Share by Type (2021–2026)
Table 53. Global Biosimilars of Factor X agonists Sales Market Share by Type (2027–2032)
Table 54. Global Biosimilars of Factor X agonists Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Biosimilars of Factor X agonists Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Biosimilars of Factor X agonists Revenue Market Share by Type (2021–2026)
Table 57. Global Biosimilars of Factor X agonists Revenue Market Share by Type (2027–2032)
Table 58. Global Biosimilars of Factor X agonists Price (US$/Unit) by Type (2021–2026)
Table 59. Global Biosimilars of Factor X agonists Price (US$/Unit) by Type (2027–2032)
Table 60. Global Biosimilars of Factor X agonists Sales (K Units) by Application (2021–2026)
Table 61. Global Biosimilars of Factor X agonists Sales (K Units) by Application (2027–2032)
Table 62. Global Biosimilars of Factor X agonists Sales Market Share by Application (2021–2026)
Table 63. Global Biosimilars of Factor X agonists Sales Market Share by Application (2027–2032)
Table 64. Global Biosimilars of Factor X agonists Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Biosimilars of Factor X agonists Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Biosimilars of Factor X agonists Revenue Market Share by Application (2021–2026)
Table 67. Global Biosimilars of Factor X agonists Revenue Market Share by Application (2027–2032)
Table 68. Global Biosimilars of Factor X agonists Price (US$/Unit) by Application (2021–2026)
Table 69. Global Biosimilars of Factor X agonists Price (US$/Unit) by Application (2027–2032)
Table 70. Generium Company Information
Table 71. Generium Description and Business Overview
Table 72. Generium Biosimilars of Factor X agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Generium Biosimilars of Factor X agonists Product
Table 74. Generium Recent Developments/Updates
Table 75. AryoGen Pharmed Company Information
Table 76. AryoGen Pharmed Description and Business Overview
Table 77. AryoGen Pharmed Biosimilars of Factor X agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. AryoGen Pharmed Biosimilars of Factor X agonists Product
Table 79. AryoGen Pharmed Recent Developments/Updates
Table 80. AMEGA Biotech Company Information
Table 81. AMEGA Biotech Description and Business Overview
Table 82. AMEGA Biotech Biosimilars of Factor X agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. AMEGA Biotech Biosimilars of Factor X agonists Product
Table 84. AMEGA Biotech Recent Developments/Updates
Table 85. Key Raw Materials Lists
Table 86. Raw Materials Key Suppliers Lists
Table 87. Biosimilars of Factor X agonists Distributors List
Table 88. Biosimilars of Factor X agonists Customers List
Table 89. Biosimilars of Factor X agonists Market Trends
Table 90. Biosimilars of Factor X agonists Market Drivers
Table 91. Biosimilars of Factor X agonists Market Challenges
Table 92. Biosimilars of Factor X agonists Market Restraints
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
Table 96. Authors List of This Report
List of Figures
Figure 1. Product Picture of Biosimilars of Factor X agonists
Figure 2. Global Biosimilars of Factor X agonists Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Biosimilars of Factor X agonists Market Share by Type: 2025 & 2032
Figure 4. 1.2mg Product Picture
Figure 5. 2.4mg Product Picture
Figure 6. Global Biosimilars of Factor X agonists Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Biosimilars of Factor X agonists Market Share by Application: 2025 & 2032
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Global Biosimilars of Factor X agonists Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Biosimilars of Factor X agonists Market Size (US$ Million), 2021–2032
Figure 13. Global Biosimilars of Factor X agonists Sales (K Units), 2021–2032
Figure 14. Global Biosimilars of Factor X agonists Average Price (US$/Unit), 2021–2032
Figure 15. Biosimilars of Factor X agonists Report Years Considered
Figure 16. Biosimilars of Factor X agonists Sales Share by Manufacturers in 2025
Figure 17. Global Biosimilars of Factor X agonists Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Biosimilars of Factor X agonists Players: Market Share by Revenue in Biosimilars of Factor X agonists in 2025
Figure 19. Biosimilars of Factor X agonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Biosimilars of Factor X agonists Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Biosimilars of Factor X agonists Sales Market Share by Country (2021–2032)
Figure 22. North America Biosimilars of Factor X agonists Revenue Market Share by Country (2021–2032)
Figure 23. United States Biosimilars of Factor X agonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Biosimilars of Factor X agonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Biosimilars of Factor X agonists Sales Market Share by Country (2021–2032)
Figure 26. Europe Biosimilars of Factor X agonists Revenue Market Share by Country (2021–2032)
Figure 27. Germany Biosimilars of Factor X agonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Biosimilars of Factor X agonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Biosimilars of Factor X agonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Biosimilars of Factor X agonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Biosimilars of Factor X agonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Biosimilars of Factor X agonists Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Biosimilars of Factor X agonists Revenue Market Share by Region (2021–2032)
Figure 34. China Biosimilars of Factor X agonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Biosimilars of Factor X agonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Biosimilars of Factor X agonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Biosimilars of Factor X agonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Biosimilars of Factor X agonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Biosimilars of Factor X agonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Biosimilars of Factor X agonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Biosimilars of Factor X agonists Sales Market Share by Country (2021–2032)
Figure 42. Latin America Biosimilars of Factor X agonists Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Biosimilars of Factor X agonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Biosimilars of Factor X agonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Biosimilars of Factor X agonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Biosimilars of Factor X agonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Biosimilars of Factor X agonists Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Biosimilars of Factor X agonists Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Biosimilars of Factor X agonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Biosimilars of Factor X agonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Biosimilars of Factor X agonists Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Biosimilars of Factor X agonists by Type (2021–2032)
Figure 53. Global Revenue Market Share of Biosimilars of Factor X agonists by Type (2021–2032)
Figure 54. Global Biosimilars of Factor X agonists Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Biosimilars of Factor X agonists by Application (2021–2032)
Figure 56. Global Revenue Market Share of Biosimilars of Factor X agonists by Application (2021–2032)
Figure 57. Global Biosimilars of Factor X agonists Price (US$/Unit) by Application (2021–2032)
Figure 58. Biosimilars of Factor X agonists Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
